Overcoming the resistance to BRAF inhibitor by the double BRAF and MEK inhibitions in advanced melanoma: a case report

被引:4
作者
Kattan, Joseph [1 ]
Kattan, Clarisse [1 ]
Farhat, Fadi [2 ]
Assi, Tarek [2 ,3 ]
机构
[1] St Joseph Univ, Hotel Dieu France Univ Hosp, Hematol Oncol Dept, Fac Med, Beirut, Lebanon
[2] Hammoud Hosp UMC, Hematol Oncol Dept, Saida, Lebanon
[3] St Joseph Univ, Hematol Oncol Dept, Fac Med, Beirut, Lebanon
关键词
binimetinib; BRAF; encorafenib; immune checkpoint; MEK; melanoma; resistance; METASTATIC MELANOMA; MUTANT MELANOMA; OPEN-LABEL; NIVOLUMAB; COMBINATION; DABRAFENIB; TRAMETINIB; IPILIMUMAB; EFFICACY; STANDARD;
D O I
10.1097/CAD.0000000000000827
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The advent of BRAF and MEK inhibitors changed the landscape of the management of BRAF mutated melanoma patients. In this article, we report the case of a 51-year-old man with BRAF mutated locally advanced cutaneous melanoma of the head who demonstrated a limited response to initial anti-BRAF monotherapy followed by extensive surgery. Anti-PD1 therapy failed to reverse the disease progression. However, subsequent double inhibition of the BRAF and MEK pathways induced a fast and remarkable tumour response.
引用
收藏
页码:1052 / 1054
页数:3
相关论文
共 50 条
[31]   Upstream mitogen-activated protein kinase (MAPK) pathway inhibition: MEK inhibitor followed by a BRAF inhibitor in advanced melanoma patients [J].
Goldinger, Simone M. ;
Zimmer, Lisa ;
Schulz, Carsten ;
Ugurel, Selma ;
Hoeller, Christoph ;
Kaehler, Katharina C. ;
Schadendorf, Dirk ;
Hassel, Jessica C. ;
Becker, Juergen ;
Hauschild, Axel ;
Dummer, Reinhard .
EUROPEAN JOURNAL OF CANCER, 2014, 50 (02) :406-410
[32]   Resistance to combination BRAF and MEK inhibition in metastatic melanoma: Where to next? [J].
Welsh, Sarah J. ;
Rizos, Helen ;
Scolyer, Richard A. ;
Long, Georgina V. .
EUROPEAN JOURNAL OF CANCER, 2016, 62 :76-85
[33]   Network indirect comparison of 3 BRAF + MEK inhibitors for the treatment of advanced BRAF mutated melanoma [J].
Consoli, F. ;
Bersanelli, M. ;
Perego, G. ;
Grisanti, S. ;
Merelli, B. ;
Berruti, A. ;
Petrelli, F. .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (06) :900-907
[34]   Combined BRAF-Targeted Therapy with Immunotherapy in BRAF-Mutated Advanced Melanoma Patients [J].
Ferrucci, Pier Francesco ;
Lens, Marko ;
Cocorocchio, Emilia .
CURRENT ONCOLOGY REPORTS, 2021, 23 (12)
[35]   Acquired and intrinsic BRAF inhibitor resistance in BRAF V600E mutant melanoma [J].
Fedorenko, Inna V. ;
Paraiso, Kim H. T. ;
Smalley, Keiran S. M. .
BIOCHEMICAL PHARMACOLOGY, 2011, 82 (03) :201-209
[36]   Development of encorafenib for BRAF-mutated advanced melanoma [J].
Koelblinger, Peter ;
Thuerigen, Olaf ;
Dummer, Reinhard .
CURRENT OPINION IN ONCOLOGY, 2018, 30 (02) :125-133
[37]   Response to Ipilimumab/Nivolumab Rechallenge and BRAF Inhibitor/MEK Inhibitor Rechallenge in a Patient with Advanced Metastatic Melanoma Previously Treated with BRAF Targeted Therapy and Immunotherapy [J].
Myrdal, Caitlyn N. ;
Sundararajan, Srinath .
CASE REPORTS IN ONCOLOGICAL MEDICINE, 2020, 2020
[38]   Combined Therapy with Anti-PD1 and BRAF and/or MEK Inhibitor for Advanced Melanoma: A Multicenter Cohort Study [J].
Huynh, Sandra ;
Mortier, Laurent ;
Dutriaux, Caroline ;
Maubec, Eve ;
Boileau, Marie ;
Dereure, Olivier ;
Leccia, Marie-Therese ;
Arnault, Jean-Philippe ;
Brunet-Possenti, Florence ;
Aubin, Francois ;
Dreno, Brigitte ;
Beylot-Barry, Marie ;
Lebbe, Celeste ;
Lefevre, Wendy ;
Delyon, Julie .
CANCERS, 2020, 12 (06) :1-11
[39]   Promising Strategies for Overcoming BRAF Inhibitor Resistance Based on Known Resistance Mechanisms [J].
Li, Qing-Shan ;
Shen, Bang-Nian ;
Xu, Hua-Jian ;
Ruan, Ban-Feng .
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2020, 20 (12) :1415-1430
[40]   Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma [J].
Ribas, Antoni ;
Lawrence, Donald ;
Atkinson, Victoria ;
Agarwal, Sachin ;
Miller, Wilson H., Jr. ;
Carlino, Matteo S. ;
Fisher, Rosalie ;
Long, Georgina V. ;
Hodi, F. Stephen ;
Tsoi, Jennifer ;
Grasso, Catherine S. ;
Mookerjee, Bijoyesh ;
Zhao, Qing ;
Ghori, Razi ;
Moreno, Blanca Homet ;
Ibrahim, Nageatte ;
Hamid, Omid .
NATURE MEDICINE, 2019, 25 (06) :936-+